{
  "study_id": "study_001",
  "study_characteristics": {
    "title": "Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States",
    "design": "Markov model-based cost-effectiveness analysis",
    "publication_year": 2016,
    "geographic_location": "United States",
    "journal_name": "Neuromodulation",
    "author_info": {
      "primary_author": "PIETZSCH ET AL.",
      "affiliation": "Not Available"
    },
    "funding_source": {
      "source": "Not Available"
    }
  },
  "population": {
    "name": "patients with advanced Parkinson's disease",
    "condition": "Parkinson's disease",
    "age_mean": 60.5,
    "sex_ratio_male": 0.64,
    "baseline_characteristics": [
      {
        "name": "Age (years)",
        "group": "Overall",
        "value": 60.5,
        "unit": "years"
      },
      {
        "name": "Male sex (%)",
        "group": "Overall",
        "value": 64.0,
        "unit": "%"
      },
      {
        "name": "Hoehn & Yahr stage",
        "group": "Both",
        "value_text": "Stratified (1-5)"
      },
      {
        "name": "\"Off\" time",
        "group": "Both",
        "value_text": "Percentage",
        "unit": "%"
      }
    ],
    "disease_classification": {
      "name": "Parkinson's disease",
      "severity": "advanced"
    },
    "target_population_age": ">65 years",
    "target_population_sex": "Both",
    "target_population_characteristics": "Medicare beneficiaries"
  },
  "interventions": [
    {
      "group": "DBS group",
      "treatment": "Deep Brain Stimulation (DBS)",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "medical_device"
    },
    {
      "group": "DBS",
      "treatment": "Deep Brain Stimulation",
      "dose": "Not specified",
      "freq": "Not specified",
      "route": "Implanted",
      "intervention_type": "medical_device"
    },
    {
      "group": "DBS cohort",
      "treatment": "Deep Brain Stimulation",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "medical_device"
    },
    {
      "group": "DBS Group",
      "treatment": "Deep Brain Stimulation",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "medical_device"
    },
    {
      "group": "DBS",
      "treatment": "Deep Brain Stimulation",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "medical_device"
    }
  ],
  "comparators": [
    {
      "group": "BMT group",
      "treatment": "Best Medical Therapy (BMT)",
      "placebo": false,
      "standard_care": true,
      "comparator_type": "standard_care",
      "number_of_comparators": 1
    },
    {
      "group": "BMT",
      "treatment": "Best Medical Therapy",
      "placebo": false,
      "standard_care": true,
      "comparator_type": "standard_care",
      "number_of_comparators": 1
    },
    {
      "group": "BMT cohort",
      "treatment": "Best Medical Therapy",
      "placebo": false,
      "standard_care": true,
      "comparator_type": "standard_care",
      "number_of_comparators": 1
    },
    {
      "group": "Control Group",
      "treatment": "Pharmaceutical therapy",
      "standard_care": true,
      "comparator_type": "standard_care"
    },
    {
      "group": "BMT",
      "treatment": "Best Medical Therapy",
      "standard_care": true,
      "comparator_type": "standard_care"
    }
  ],
  "economic_data": {
    "effectiveness_utility": {
      "utility_types": "EQ-5D",
      "health_state_utilities": [
        {
          "health_state_name": "H&Y stage 1",
          "utility_value": 0.645,
          "confidence_interval_lower": 0.51,
          "confidence_interval_upper": 0.78
        },
        {
          "health_state_name": "H&Y stage 2",
          "utility_value": 0.605,
          "confidence_interval_lower": 0.49,
          "confidence_interval_upper": 0.72
        },
        {
          "health_state_name": "H&Y stage 3",
          "utility_value": 0.51,
          "confidence_interval_lower": 0.38,
          "confidence_interval_upper": 0.64
        },
        {
          "health_state_name": "H&Y stage 4",
          "utility_value": 0.255,
          "confidence_interval_lower": 0.12,
          "confidence_interval_upper": 0.39
        },
        {
          "health_state_name": "H&Y stage 5",
          "utility_value": 0.0,
          "confidence_interval_lower": -0.13,
          "confidence_interval_upper": 0.13
        },
        {
          "health_state_name": "Baseline PD",
          "utility_value": 0.39,
          "measurement_instrument": "Model-derived"
        },
        {
          "health_state_name": "Post-DBS treatment",
          "utility_value": 0.613,
          "measurement_instrument": "Model-derived"
        }
      ],
      "health_state_transitions": [
        {
          "from_state": "Any",
          "to_state": "Withdrawal from DBS",
          "transition_probability": 0.1
        },
        {
          "from_state": "Withdrawal from DBS",
          "to_state": "Continued withdrawal",
          "transition_probability": 0.02
        }
      ]
    },
    "model_parameters": {
      "health_states": [
        "H&Y stage 1",
        "H&Y stage 2",
        "H&Y stage 3",
        "H&Y stage 4",
        "H&Y stage 5",
        "Death",
        "H&Y 1",
        "H&Y 2",
        "H&Y 3",
        "H&Y 4",
        "H&Y 5"
      ],
      "time_horizon_year": 10.0,
      "discount_rate": 0.03,
      "WTP_threshold": 50000.0,
      "time_horizon": "10 years",
      "perspectives": [
        "healthcare_system",
        "payer"
      ],
      "cost_discounted": true,
      "discount_rate_cost": 0.03,
      "outcome_discounted": true,
      "discount_rate_outcome": 0.03,
      "sensitivity_analysis": true,
      "sensitivity_analysis_type": [
        "one_way",
        "one_way",
        "scenario",
        "one_way",
        "scenario",
        "threshold",
        "one_way"
      ],
      "cost_effectiveness_thresholds": [
        50000.0,
        150000.0,
        50000.0
      ],
      "health_state_definitions": [
        "Hoehn & Yahr stages with 'off' time percentages (0-25%, 26-50%, 51-75%, 76-100%)"
      ],
      "cycle_length": "6 months",
      "model_type": "Markov"
    },
    "icer_analysis": {
      "icer_value": 23404.0,
      "number_of_ratios": 1,
      "ratio_quadrant": "SE"
    },
    "currency_info": {
      "currency_country": "United States",
      "currency_year": 2014,
      "currency_code": "USD"
    },
    "treatment_group_costs": [
      {
        "treatment_group": "DBS",
        "cost_components": [
          {
            "component_name": "DBS implantation",
            "unit_cost": 33319.0,
            "unit": "per procedure",
            "cost_category": "procedure",
            "source": "2014 Medicare MS-DRG and physician fee schedule",
            "cost_description": "Generator, leads, physician fees"
          },
          {
            "component_name": "Infection management",
            "unit_cost": 23441.0,
            "unit": "per event",
            "cost_category": "complication",
            "source": "FY 2014 Medicare reimbursement",
            "cost_description": "DBS-related infection treatment"
          },
          {
            "component_name": "Device complication",
            "unit_cost": 15902.0,
            "unit": "per event",
            "cost_category": "complication",
            "source": "FY 2014 Medicare reimbursement",
            "cost_description": "DBS device complication management"
          },
          {
            "component_name": "Explantation",
            "unit_cost": 4918.0,
            "unit": "per procedure",
            "cost_category": "procedure",
            "source": "FY 2014 Medicare reimbursement",
            "cost_description": "DBS removal"
          },
          {
            "component_name": "Neurostimulator replacement",
            "unit_cost": 26653.0,
            "unit": "per procedure",
            "cost_category": "procedure",
            "source": "Medicare APC 0039/0315 plus CPT codes",
            "cost_description": "Generator replacement"
          },
          {
            "component_name": "Pre-operative assessment",
            "unit_cost": 432.0,
            "unit": "per patient",
            "cost_category": "diagnostic",
            "source": "CPT 70450, 70551, 99205",
            "cost_description": "CT, MRI and evaluation"
          }
        ]
      },
      {
        "treatment_group": "BMT"
      },
      {
        "treatment_group": "DBS cohort",
        "total_cost": 130510.0
      },
      {
        "treatment_group": "BMT cohort",
        "total_cost": 91026.0
      },
      {
        "treatment_group": "Control Group",
        "total_cost": 91026.0,
        "cost_components": [
          {
            "component_name": "Baseline pharmaceutical costs",
            "total_cost": 91026.0
          }
        ]
      },
      {
        "treatment_group": "DBS Group",
        "total_cost": 109085.0,
        "cost_components": [
          {
            "component_name": "DBS-related procedure costs",
            "total_cost": 109085.0,
            "cost_description": "Low scenario (230% of baseline)"
          },
          {
            "component_name": "Fall-related medical care",
            "total_cost": 46160.0,
            "cost_description": "High scenario (200% of baseline)"
          },
          {
            "component_name": "Pharmaceutical costs",
            "total_cost": 37042.0,
            "cost_description": "Based on Average Wholesale Price"
          }
        ]
      }
    ]
  },
  "outcomes": [
    {
      "name": "Falls requiring medical care",
      "outcome_type": "safety",
      "time_point": "During treatment",
      "unit": "Probability",
      "group_results": [
        {
          "group": "DBS",
          "value": 0.62
        }
      ]
    },
    {
      "name": "Mortality risk",
      "outcome_type": "safety",
      "unit": "Relative risk",
      "group_results": [
        {
          "group": "H&Y 2",
          "value": 2.03
        },
        {
          "group": "H&Y 3",
          "value": 2.16
        },
        {
          "group": "H&Y 4/5",
          "value": 4.99
        }
      ],
      "ci95_lower": 1.0,
      "ci95_upper": 4.99
    },
    {
      "name": "QALY gain",
      "outcome_type": "economic",
      "unit": "QALYs",
      "group_results": [
        {
          "group": "DBS Group",
          "value": 3.19
        },
        {
          "group": "Control Group",
          "value": 1.5
        }
      ]
    }
  ]
}